Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies.
Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clin Microbiol Infect. 2022 Oct; 28(10):1321-1327.